Use of a Hospital Database to Determine the Characteristics of Diagnostic Tests

1990 ◽  
Vol 29 (03) ◽  
pp. 205-212 ◽  
Author(s):  
Johanna Zwetsloot-Schonk

AbstractTest indices are often determined by comparing test results of healthy persons with test results of patients known to have the disease. However, the patient population for which the test is ordered in clinical practice often differs from the study population on which the test indices are based. Hence, these indices are not applicable to clinical practice and should be recalculated using data from daily clinical practice. Two major problems of using routinely collected data are discussed: the assessment of the final health status and tracing the reason for ordering the test. Prior considerations are given to the use of hospital information systems (HIS) to sample the patient population that is desired and to collect the necessary data for calculating test indices. We investigated whether the HIS of Leiden University Hospital (which is presented as an example) can be used to calculate the indices of clinical laboratory tests, histopathologic examinations and radiodiagnostic investigations. The results indicate that the registration of diagnoses must be improved and that a way must be found to capture the implicit reasoning for ordering diagnostic tests.

Author(s):  
Wendy P.J. den Elzen ◽  
Nannette Brouwer ◽  
Marc H. Thelen ◽  
Saskia Le Cessie ◽  
Inez-Anne Haagen ◽  
...  

AbstractBackgroundExternal quality assessment (EQA) programs for general chemistry tests have evolved from between laboratory comparison programs to trueness verification surveys. In the Netherlands, the implementation of such programs has reduced inter-laboratory variation for electrolytes, substrates and enzymes. This allows for national and metrological traceable reference intervals, but these are still lacking. We have initiated a national endeavor named NUMBER (Nederlandse UniforMe Beslisgrenzen En Referentie-intervallen) to set up a sustainable system for the determination of standardized reference intervals in the Netherlands.MethodsWe used an evidence-based ‘big-data’ approach to deduce reference intervals using millions of test results from patients visiting general practitioners from clinical laboratory databases. We selected 21 medical tests which are either traceable to SI or have Joint Committee for Traceability in Laboratory Medicine (JCTLM)-listed reference materials and/or reference methods. Per laboratory, per test, outliers were excluded, data were transformed to a normal distribution (if necessary), and means and standard deviations (SDs) were calculated. Then, average means and SDs per test were calculated to generate pooled (mean±2 SD) reference intervals. Results were discussed in expert meetings.ResultsSixteen carefully selected clinical laboratories across the country provided anonymous test results (n=7,574,327). During three expert meetings, participants found consensus about calculated reference intervals for 18 tests and necessary partitioning in subcategories, based on sex, age, matrix and/or method. For two tests further evaluation of the reference interval and the study population were considered necessary. For glucose, the working group advised to adopt the clinical decision limit.ConclusionsUsing a ‘big-data’ approach we were able to determine traceable reference intervals for 18 general chemistry tests. Nationwide implementation of these established reference intervals has the potential to improve unequivocal interpretation of test results, thereby reducing patient harm.


2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
A Kaura ◽  
J Davies ◽  
V Panoulas ◽  
B Glampson ◽  
A Mulla ◽  
...  

Abstract Background Many of the data points required to support translational research are collected as a matter of routine, and should be available within electronic patient records. Variations in clinical and data recording practice can mean that the extraction and standardisation of this data, with the aim of producing a large-scale, research-ready dataset, presents a number of challenges. Purpose We set out to create a large-scale, research-ready dataset to support translational research in cardiovascular medicine, using routinely-collected data from five large university-hospital partnerships. As an initial focus, we selected those data points that would support an investigation of the relationship between test results and outcomes in acute coronary syndrome (ACS). Methods The National Institute of Health Research (NIHR) Health Informatics Collaborative (HIC) is a programme of infrastructure development aimed at increasing the quality and availability of routinely-collected data for collaborative, translational research. Eighteen university-hospital partnerships signed the data sharing agreement, and are working to facilitate the sharing and re-use of data across centres, for approved research purposes. With support from the Directors of the NIHR Biomedical Research Centres (BRCs) within five of the largest partnerships, we established a clinical data collaboration, specifying a dataset and selecting an initial research question (Figure 1). The NIHR HIC team worked to extract data against this specification. With approval from an ethics committee, and from the information governance teams at each contributing centre, data was processed by one of the centres for standardisation and analysis. Results The specified dataset represented a longitudinal record for patients presenting with a suspected ACS, characterised by a request for a troponin test (Figure 1). The dataset included 156 data points, grouped into demographics, cardiovascular risk factor profile, emergency department attendance and inpatient episodes, blood tests, echocardiography and mortality. Data was extracted from the records of patients for whom a troponin test was requested between 2010 and 2017. A total of 257,948 records were standardised and analysed. The collaboration has been successful, and an initial version of the combined dataset has been created. The size of the dataset has yielded new insights into the relationship between test results and outcomes, and publications are in preparation. An expanded dataset of over 800 data points has been agreed for the next phase of the collaboration, and three other centres have joined. Figure 1. NIHR HIC dataset generation Conclusion It is perfectly feasible – in terms of governance and technology – to re-use routinely-collected data for collaborative, translational research in cardiovascular medicine. The resulting dataset will be large and complex enough to require big data tools and techniques, and will yield the kind of insights afforded only by big data in medicine. Acknowledgement/Funding Funded by NIHR Imperial Biomedical Research Centre (BRC) using NIHR Health Informatics Collaborative data service, supported by OUH, GSTT & UCLH BRCs


2018 ◽  
Vol 09 (01) ◽  
pp. 106-111 ◽  
Author(s):  
Alev Selek ◽  
Berrin Cetinarslan ◽  
Zeynep Canturk ◽  
Ilhan Tarkun ◽  
Ozlem Zeynep Akyay ◽  
...  

ABSTRACT Purpose: Cushing's syndrome (CS) is a rare disease having diagnostic difficulties. Many diagnostic tests have been defined but none of these are diagnostic alone. Determination of the cause is another problem which sometimes requires more sophisticated and invasive procedures. Therefore, we aimed to evaluate the utility of pretreatment plasma adrenocorticotropic hormone (ACTH)/cortisol ratios in patients with confirmed endogenous CS for the diagnosis and differential diagnosis of CS. Materials and Methods: This retrospective evaluation included 145 patients with the diagnosis of CS, 119 patients with Cushing's disease (CD), and 26 patients with ACTH-independent CS (AICS), in a university hospital. Furthermore, 114 individuals in whom CS diagnosis was excluded with at least one negative screening test were enrolled to the study as control group. The clinical, laboratory, imaging, postsurgical pathologic records and also clinical follow-up data of all patients were evaluated. Results: The median basal ACTH/cortisol ratio of the patients with CD was significantly higher than AICS and controls. A cutoff ACTH/cortisol ratio >2.5 was found to be diagnostic for CD with 82% specificity and 63% sensitivity. Among CD group, patients with recurrent disease had higher preoperative ACTH levels and ACTH/cortisol ratio than patients with sustained remission. Furthermore, these patients had more invasive, atypical, and larger tumors. Conclusion: An ACTH/cortisol ratio >2.5 would be beneficial to diagnose CD together with other diagnostic tests. It is a simple test with no additional cost. Higher ratios might be related with larger, invasive, and atypical adenoma and also might be helpful to predict recurrence.


2021 ◽  
Vol 27 ◽  
pp. 107602962110579
Author(s):  
Falmata Laouan Brem ◽  
Boudouh Asmae ◽  
Yassine Amane ◽  
Mohammed-Amine Bouazzaoui ◽  
Miri Chaymae ◽  
...  

Importance Proinflammatory and hypercoagulable states with marked elevation seen in D-Dimer levels have been accurately described in patients infected by the SARS- Cov2 even without pulmonary embolism (PE). Objectives To compare D-dimers values in patients infected by the novel Coronavirus 2019 (COVID-19) with and without PE and to establish an optimal D-dimer cut-off to predict the occurrence of PE, which guides pulmonary computed tomography angiography (CTPA) indication. Methods We retrospectively enrolled all COVID-19-patients admitted between October first and November 22th, 2020, at the University Hospital Center of Mohammed VI, Oujda (Morocco), suspected to have PE and underwent a CTPA. Demographic characteristics and blood test results were compared between PE-positive and PE-negative. The receiver operating characteristics (ROC) curve was constructed to establish an optimal D-Dimer cut-off to predict the occurrence of PE. Results The study population consisted of 84 confirmed COVID-19-patients. The mean age was 64.93 years (SD 14.19). PE was diagnosed on CTPA in 31 (36.9%) patients. Clinical symptoms and in-hospital outcomes were similar in both groups except that more men had PE ( p = .025). The median value of D-dimers in the group of patients with PE was significantly higher (14 680[IQR 33620-3450]ng/mL compared to the group of patients without PE 2980[IQR 6870-1600]ng/mL [P < .001]. A D-dimer at 2600 ng/mL was the optimal cut-off for predicting PE with a sensitivity of 90.3%, and AUC was .773[CI 95%, .667 −.876). Conclusion A D-dimer cut-off value of 2600 ng/mL is a significant predictor of PE in COVID-19-patients with a sensitivity of 90.3%.


2021 ◽  
Author(s):  
Eiko I Fried ◽  
Edwin de Beurs

Objective. There is a great variety of measurement instruments to assess similar constructs in experimental psychological research and clinical practice. This complicates the interpretation of measurement results and hampers the implementation of measurement-based care. Actions have been proposed to improve matters, such as mandating a limited set of outcome measures as a prerequisite to obtain research funding. Method. We propagate an alternative or supplementary strategy: converting test results into universally applicable common metrics. Results. Two metrics are reviewed: T scores and percentile ranks. Their calculation is explained, and their merits and shortcomings discussed using data from three common measures for depression, the CES-D, PHQ-9, and BDI-II. Conclusion. We conclude with a proposal to express test results as T scores with the general population as reference group and supplement these with percentile ranks based on data from clinical and population samples.


2020 ◽  
Vol 15 ◽  
Author(s):  
Samah Awad ◽  
Rawan Hatim ◽  
Yousef Khader ◽  
Mohammad Alyahya ◽  
Nada Harik ◽  
...  

Background: Bronchiolitis is a leading cause of hospital admissions and death in young children. Clinical practice guidelines (CPG) to diagnose and manage bronchiolitis have helped healthcare providers to avoid unnecessary investigations and interventions and to provide evidence-based treatment. Aim of this study is to determine the effect of implementing CPG for the diagnosis and management of bronchiolitis in a tertiary hospital in Jordan. Methods: The study compared children (age <24 months) diagnosed with bronchiolitis and who required admission to King Abdullah University Hospital in Irbid during the winter of 2017 (after CPG implementation) and age-matched children admitted in the winter of 2016. The proportion of patients receiving diagnostic tests and treatments in the two groups were compared.Results: Eighty-eight and 91 patients were diagnosed with bronchiolitis before and after CPG implementation, respectively. Respiratory syncytial virus rapid antigen detection testing decreased after CPG implementation [n=64 (72.7%) vs n=46 (50.5%), p=0.002]. However, there was no significant change in terms of other diagnostic tests. The use of nebulized salbutamol [n=44 (50%) vs n=29 (31.9%), p=0.01], hypertonic saline [n=39 (44.3%) vs n=8 (8.8%), p<0.001], and inappropriate antibiotics [n=31 (35.2%) vs n=15 (16.5%), p=0.004] decreased after CPG implementation. There was no difference in mean LOS (standard deviation; SD) between the pre- and post-CPG groups [3.5 (2) vs 4 (3.4) days, p=0.19]. The mean cost of stay (SD) was 449.4 (329.1) US dollars for pre-CPG compared to 507.3 (286.1) US dollars for the post-CPG group (p=0.24).Conclusion: We observed that the implementation of CPG for bronchiolitis diagnosis and management helped change physicians’ behavior toward evidence-based practices. However, adherence to guidelines must be emphasized to improve practices in developing countries, focusing on the rational use of diagnostic testing, and avoiding use of unnecessary medications when managing children with a diagnosis of bronchiolitis.


Author(s):  
Putu Bagus Adidyana Anugrah Putra

During January-April 2020, a number of flights were canceled to reduce the risk of contracting COVID-19. Flights were reopened when the government relaxed the PSBB in mid-May 2020. However, aviation activities must comply with health protocols. One of the requirements for traveling by plane is to show a letter of negative PCR test results for COVID-19 or rapid test with non-reactive results. The medical clinical laboratory in registering the rapid test is still manual so that the general public who wants to travel by plane in carrying out a rapid test must be served from registration to completion at the clinic. So that sometimes there is an accumulation of people who want a rapid test. It is necessary to make a registration system for rapid tests in medical clinics using the waterfall method. The stages of system development are business process modeling using Data Flow Diagrams (DFD) and Entity Relationship Diagrams (ERD), user interface design, and the testing process will be carried out with a blackbox. The system developed can reduce the accumulation of patients in the clinic. From the test results, the system functionality can run well


1990 ◽  
Vol 29 (03) ◽  
pp. 213-220 ◽  
Author(s):  
Johanna H. M. Zwetsloot-Schonk ◽  
J. Hermans ◽  
Marijke Frolich ◽  
P. Snitker ◽  
J. Zwartendijk ◽  
...  

AbstractIndices of diagnostic tests, such as sensitivity and specificity, should be determined using diagnostic test results of patients tested in clinical practice. Hospital information systems that store data on diagnostic tests and diagnoses might be used for sampling the desired study population and in the actual process of collecting the data.This paper presents, as an example, a study calculating the sensitivity and specificity of the prostate-specific acid phosphatase test. All data needed in the study were obtained from the hospital information system of Leiden University Hospital. The final health status of each patient was assessed by the cancer registry of the system. The reason for ordering the test was deduced from data on histopathological examinations of prostatic tissue. The actual selections made from the central database are described in dataflow diagrams. The sensitivity of the test was found to be 0.34 and the specificity 0.88, using a discrimination value o f 1.00 U/I. The impact of the reason for ordering the test on the specificity is illustrated. Possible biases of these measured values are discussed.


2020 ◽  
Vol 35 (1) ◽  
pp. 93-96
Author(s):  
Ítalo José Lemos de Oliveira ◽  
Raquel de Arruda Campos Benjamim ◽  
Thayanne Breckenfeld Meneses ◽  
Ana Jessyca da Silva Costa ◽  
Jarson Pedro da Costa Pereira ◽  
...  

Introduction: Obesity is an internationally health crisis. The bariatric surgery offers treatment to reduce body weight, induce remission of obesity-related diseases and improve quality of life. Nutritional deficiencies may have been installed even before surgery, and preoperative anemia is an independent risk factor. Thus, the present study aims to evaluate iron deficiency in obese candidates for bariatric surgery, attending a nutrition ambulatory of a university hospital in Recife/Brazil. Methods: Cross-sectional, descriptive study. The patients were evaluated according to sex, age, weight, body mass index (BMI), iron and ferritin levels. Iron deficiency was classified by levels <50 Ug/dl and <65 Ug/dl for women and men, respectively. The ferritin levels classified as deficient were those below 15 ng/ml for both sexes. Data collection was performed from May 2017 to June 2018, using data from nutrition setting’s monitoring forms. Data were tabulated and analyzed using Microsoft Excel software version 10. Results: 75 patients were included, with prevalence of women (85.3%), mean BMI of 47.99 ± 7.56 kg/m2. The means of serum iron (n = 70) and ferritin (n = 60) were 76.33 ± 37.06 Ug/dl and 160.82 ± 159.43 ng/ml, respectively. There was a high prevalence of serum iron deficiency (62.9%); however, ferritin was deficient in only 1.7% of the study population. Conclusion: This study observed an important presence of iron deficiency in the group of obese patients evaluated, with the greatest sensitivity being detected by means of serum iron. The biochemical evaluation of the patient who will be submitted to the bariatric procedure is important, in order to avoid health issues and postoperative complications, thus helping in their recovery.


1993 ◽  
Vol 12 (3) ◽  
pp. 98-109 ◽  
Author(s):  
P.L. Pelmear ◽  
R. Kusiak ◽  
B. Dembek

Three hundred and sixty-four patients exposed to hand-arm vibration at work were assessed in a clinical laboratory designated for this purpose in Toronto, Canada during the period 1989–92. The assessment included completion of a subjective history questionnaire; a medical examination of the upper torso, cardiovascular and central nervous systems; and multiple vascular, sensorineural and laboratory tests. The test results were used to assess the severity of Hand-arm Vibration Syndrome (HAVS) and grade the subjects according to the Stockholm stages. A statistical clustering algorithm was used to categorise the subjects according to the results of their diagnostic tests. One set of clusters was made from the vascular test results and another from the sensory test results. These clusters were compared with the Stockholm history (SH) and diagnostic (SD) stages. The clusters based upon the vascular test results (the vascular clusters) agreed well with the SD vascular stages (P= 1×10−9), and less well with the SD sensorineural stages (P=0.04). The clusters based upon the sensory test results (the sensory clusters) agreed well with the SD sensorineural stages (P=0.0003), and less well with the SD vascular stages (P=0.03). The mean values for the diagnostic tests within the clusters were compared. The sensory test results differed between the sensory clusters while most vascular test results did not. Likewise, the vascular test results differed between the vascular clusters while most sensory tests did not. A comparison of the vascular and sensory clusters showed that while some men suffered severe sensory effects and others suffered severe vascular effects, few suffered both. Hence this analysis confirms that the severity grading of sensory and vascular components of HAVS must be evaluated separately as now practised. This cluster analysis technique (SAS'S FASTCLUS procedure) has proved to be useful for the objective analysis of the results from many diagnostic tests on a large group of individuals. The reference data of the tests within the cluster groupings provides a basis for the objective classification of the severity of HAVS in individual patients.


Sign in / Sign up

Export Citation Format

Share Document